Ignite Creation Date:
2024-05-06 @ 5:48 PM
Last Modification Date:
2024-10-26 @ 2:35 PM
Study NCT ID:
NCT05434286
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-05-01
First Post:
2022-06-13
Brief Title:
Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function Renal and Cardiac Biomarkers in Cirrhosis With Hepatorenal Syndrome-Acute Kidney Injury
Sponsor:
Post Graduate Institute of Medical Education and Research Chandigarh
Organization:
PGIMER
Study Overview
Official Title:
Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function Renal and Cardiac Biomarkers in Cirrhosis With Hepatorenal Syndrome-Acute Kidney Injury
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Point-of-care echocardiography POC-Echo is used to determine left ventricular systolic and diastolic dysfunction LVDD inferior vena cava IVC dynamics and volume status in cirrhosis and Acute-on-chronic liver failure ACLF accurately
We will assess IVC dynamics LV systolic function LV ejection fraction EF cardiac output CO and diastolic dysfunction Ee e and EA ratio and urinary biomarkers cystatin C and NGAL in patients with cirrhosis and ACLF with hepatorenal syndrome-acute kidney injury HRS-AKI
We will assess IVC dynamics LV systolic function LV ejection fraction EF cardiac output CO and diastolic dysfunction Ee e and EA ratio and urinary biomarkers cystatin C and NGAL in patients with cirrhosis and ACLF with hepatorenal syndrome-acute kidney injury HRS-AKI
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None